XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Dec. 24, 2022
Dec. 25, 2021
Cash flows from operating activities:    
Net income $ 230,372 $ 229,941
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 52,358 45,156
Stock-based compensation expense 59,108 49,368
Deferred income taxes 6,430 (8,243)
Loss on retirement or write-off of long-lived assets 306 527
Other non-cash adjustments 3,017 282
Net change in operating assets and liabilities:    
Accounts receivable, net (30,229) (210,694)
Inventories (13,990) 32,413
Prepaid wafers 0 (195,000)
Other assets 4,516 (101,160)
Accounts payable and other accrued liabilities (26,619) (12,720)
Income taxes payable (3,455) 159
Acquisition-related liabilities 9,488 36,493
Net cash provided by (used in) operating activities 291,302 (133,478)
Cash flows from investing activities:    
Maturities and sales of available-for-sale marketable securities 10,346 366,582
Purchases of available-for-sale marketable securities (9,469) (77,716)
Purchases of property, equipment and software (23,764) (18,091)
Investments in technology (1,315) (3,463)
Acquisition of business, net of cash obtained 0 (276,884)
Net cash used in investing activities (24,202) (9,572)
Cash flows from financing activities:    
Debt issuance costs 0 (1,718)
Payment of acquisition-related holdback (30,949) 0
Issuance of common stock, net of shares withheld for taxes 1,524 8,562
Repurchase of stock to satisfy employee tax withholding obligations (16,563) (18,335)
Repurchase and retirement of common stock (156,382) (92,502)
Net cash used in financing activities (202,370) (103,993)
Net increase (decrease) in cash and cash equivalents 64,730 (247,043)
Cash and cash equivalents at beginning of period 369,814 442,164
Cash and cash equivalents at end of period $ 434,544 $ 195,121